UPDATE 1-Lundbeck to buy U.S. firm Chelsea Therapeutics for up to $658 mln
[Reuters] – * Consideration represents a 59 pct premium for Chelsea shares * Northera drug could become Lundbeck’s most valuable neurological drug in the U.S * Deal still requires approval of Chelsea shareholders COPENHAGEN, May 8 (Reuters) – Danish phar more
View todays social media effects on CHTP
View the latest stocks trending across Twitter. Click to view dashboard